A Phase I Study of Cetuximab in Combination With Erlotinib in Patients With Advanced Solid Malignancies
A Phase I Study of Cetuximab in Combination With Erlotinib in Patients With Advanced Solid Malignancies
The purpose of this study is to find a safe and effective dose of the combination of cetuximab (Erbitux) and Tarceva (erlotinib).
Inclusion Criteria:
Exclusion Criteria: